Spoken Alpha
Solventum Corp
Solventum manufactures and sells medical devices, dental products, and healthcare software across three business segments: MedSurg (wound care, surgical supplies, infection prevention), Dental Solutions (orthodontic and restorative products), and Health Information Systems (revenue cycle and clinical documentation software).
Solventum Corp is a Healthcare company operating in Medical Instruments & Supplies with a $14.90B market cap.
Most recent reported earnings: Q3 FY2026 (Nov 4, 2026).
9 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Disclosures
Extracted from Unknown source, 2026-08-30.
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
Peers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for SOLV.
$ curl https://api.spokenalpha.com/v1/companies/SOLVFAQ
Spoken Alpha indexes SOLV's earnings call transcripts at https://spokenalpha.com/companies/SOLV. Each call links to attributed speakers and parsed analyst Q&A. Solventum Corp's own investor relations page is at https://investors.solventum.com/.
Solventum Corp (SOLV) held its most recent earnings call on 2026-08-05, covering fiscal Q2 2026.
Solventum Corp (SOLV) operates in the Healthcare sector (Medical Instruments & Supplies industry).
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-11-04 | — | $1.37 | — | — | — | — | EODHD |
| Q2 FY2026 | 2026-08-04 | $2.55 | $1.91 | +33.5% | $2.21B | — | — | EODHD |
| Q1 FY2026 | 2026-05-04 | $1.48 | $1.35 | +9.6% | $2.01B | — | — | EODHD |
| Q4 FY2025 | 2026-02-25 | $1.57 | $1.50 | +4.7% | $2.00B | — | — | EODHD |
| Q3 FY2025 | 2025-11-05 | $1.50 | $1.43 | +4.9% | $2.10B | — | — | EODHD |
| Q2 FY2025 | 2025-08-06 | $1.69 | $1.45 | +16.6% | $2.16B | — | — | EODHD |
| Q1 FY2025 | 2025-05-07 | $1.34 | $1.22 | +9.8% | $2.07B | — | — | EODHD |
| Q4 FY2024 | 2025-02-26 | $1.41 | $1.50 | -6.0% | $2.08B | — | — | EODHD |
| Q3 FY2024 | 2024-11-06 | $1.64 | $1.39 | +18.0% | $2.08B | — | — | EODHD |
| Q2 FY2024 | 2024-08-07 | $1.56 | $1.51 | +3.3% | $2.08B | — | — | EODHD |
| Q1 FY2024 | 2024-05-08 | $2.08 | $1.75 | +18.9% | $2.02B | — | — | EODHD |
| Q4 FY2023 | 2024-02-27 | $2.31 | $0.00 | — | $2.04B | — | — | EODHD |
Source: EODHD. SOLV reported actuals as published; sparse fields render as —.